Skip to main content
LONA
NASDAQ Life Sciences

LeonaBio's 23M Series A Warrants Now Exercisable, Potential $146.2M Cash Inflow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$6.05
Mkt Cap
$57.001M
52W Low
$3.6
52W High
$14.21
52W Position info
68% above low
Off High info
57% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LONA sits 68% above its 52-week low of $3.6.

Summary

LeonaBio's 23M Series A warrants are now exercisable, potentially bringing in $146.2M in cash if fully exercised. The exercise window runs through October 19, 2026.


Key Events · Financing and Capital Events · LONA

  • Series A Warrants Exercisable

    23,031,494 Series A Common Warrants became exercisable on September 18, 2026, and remain exercisable until October 19, 2026.

  • Potential $146.2M Cash Inflow

    If exercised in full for cash at $6.35 per share, the warrants would provide approximately $146.2 million of additional capital.

  • Exercise Price Above Market

    The $6.35 exercise price is above the current stock price of $6.05, which may lead holders to choose cashless exercise or let warrants expire.

  • Going Concern Context

    The company's last 10-Q disclosed a going concern warning with $51.1M in cash that may not last 12 months, making this potential capital infusion critical.


Analysis · LONA · Life Sciences

The Series A Common Warrants became exercisable on September 18, 2026, and remain exercisable until October 19, 2026. If exercised in full for cash, they would provide approximately $146.2 million of additional capital. This is a significant potential financing event for a company with a going concern warning and only $51.1 million in cash as of its last 10-Q. The exercise price of $6.35 per share is above the current stock price of $6.05, which may influence whether holders choose to exercise for cash or on a cashless basis.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LONA was trading at $6.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $57M. The 52-week trading range was $3.60 to $14.21. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LONA - Latest Insights

LONA
Aug 31, 2026, 4:31 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $7.92
Real-time Price: $3.39 info
Change: -$4.53 (-57%) info
Market Cap: $31.939M info
LONA
Aug 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $3.39 info
Change: -$4.62 (-58%) info
Market Cap: $31.939M info
LONA
Aug 14, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.97
Real-time Price: $3.39 info
Change: -$4.57 (-57%) info
Market Cap: $31.939M info
LONA
Aug 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.97
Real-time Price: $3.39 info
Change: -$4.57 (-57%) info
Market Cap: $31.939M info
LONA
May 11, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $10.01
Real-time Price: $3.39 info
Change: -$6.62 (-66%) info
Market Cap: $31.939M info